Perrigo (PRGO) Times Interest Earned (2013 - 2026)
Perrigo's (PRGO) quarterly Times Interest Earned came in at -$17.9 in Q1 2026, down 851.84% year-on-year from $2.38 in Q1 2025, and down 142.67% on a QoQ basis from -$7.38 in Q4 2025.
Perrigo (PRGO) Times Interest Earned (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Times Interest Earned data on file, last reported at -$17.9 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 851.84% year-over-year to -$17.9 in Q1 2026; TTM through Mar 2026 was -$74.11, a 779.02% decrease from a year earlier, with the FY2025 full-year figure at -$1.81, down 2391.85% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$17.9, down from -$7.38 in the prior quarter.
- Over the last five years, Times Interest Earned for PRGO reached as high as $18.72 in Q4 2024 and fell as low as -$17.9 in Q1 2026.
- Historically, Times Interest Earned has averaged $0.25 across 5 years, with a median of $0.24 in 2023.
- Across the five-year window, Times Interest Earned surged 30090.1% in 2024 and tumbled 851.84% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at $0.17 in 2022, then sank by 137.54% to -$0.06 in 2023, then surged by 30090.1% to $18.72 in 2024, then sank by 139.4% to -$7.38 in 2025, then slumped by 142.67% to -$17.9 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$17.9 in Q1 2026, -$7.38 in Q4 2025, and $3.1 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -17.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -17.90 |
| Dec 31, 2025 | -7.38 |
| Sep 27, 2025 | 3.10 |
| Jun 28, 2025 | 1.50 |
| Mar 29, 2025 | 2.38 |
| Dec 31, 2024 | 18.72 |
| Sep 28, 2024 | 0.36 |
| Jun 29, 2024 | -0.12 |
| Mar 30, 2024 | -2.44 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | 2.75 |
| Jul 1, 2023 | 0.24 |
| Apr 1, 2023 | 2.12 |
| Dec 31, 2022 | 0.17 |
| Oct 1, 2022 | 0.14 |
| Jul 2, 2022 | -0.03 |
| Apr 2, 2022 | 0.77 |
| Dec 31, 2021 | 0.44 |
| Oct 2, 2021 | 16.11 |
| Jul 3, 2021 | -3.83 |